FDA Inspection 1071935 — Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II
The FDA completed an inspection of Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II on Sep 21, 2018 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional details
Clinical BA/BE